Howard Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-175
Closed -$5K 124
2019
Q4
$5K Buy
+175
New +$5.56K ﹤0.01% 386

Other funds holding ARKG

Howard Wealth Management's ARKG Position: Q1 2020 in Review

Howard Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2020, closing a stake of 175 shares — an estimated $5K sold.

Howard Wealth Management first reported a position in ARKG in Q4 2019 and held it in 1 quarter. The position peaked at $5K in Q4 2019. 106 funds tracked by Wall St. Rank hold ARKG as of Q1 2020.

  • Howard Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2020 after selling out during the quarter.
  • Howard Wealth Management sold 175 ARK Genomic Revolution ETF shares in Q1 2020, an estimated $5K.
  • Howard Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2019 and held it in 1 quarter.
  • Howard Wealth Management's ARK Genomic Revolution ETF position peaked at $5K in Q4 2019.
  • 106 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2020.

Based on Howard Wealth Management's 13F filing for Q1 2020, filed 4 May 2020.